| scholarly article | Q13442814 |
| P2093 | author name string | C Wang | |
| M J During | |||
| G Metzger | |||
| E Kocak | |||
| A Muravlev | |||
| K H Carruthers | |||
| P2860 | cites work | Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. | Q33713108 |
| Adeno-associated virus as a gene delivery system | Q33933129 | ||
| Gene therapy in plastic surgery | Q34511799 | ||
| Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent | Q34720809 | ||
| Adenoassociated virus vectors for genetic immunization | Q34981939 | ||
| Follow-up after curative resection of colorectal cancer: a meta-analysis | Q36943822 | ||
| Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates | Q37000577 | ||
| Plastic surgical delivery systems for targeted gene therapy. | Q37149879 | ||
| Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. | Q37426975 | ||
| Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT. | Q37954731 | ||
| Local chemotherapeutic agents for the treatment of ocular malignancies | Q38151280 | ||
| Using genetically modified microvascular free flaps to deliver local cancer immunotherapy with minimal systemic toxicity | Q39985784 | ||
| Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy | Q40000027 | ||
| A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein. | Q40450759 | ||
| Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity. | Q40469180 | ||
| Incidence and patterns of recurrence following curative resection for colorectal carcinoma | Q41431291 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Fat grafting as a vehicle for the delivery of recombinant adenoassociated viral vectors to achieve gene modification of muscle flaps | Q42638545 | ||
| Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus | Q43134453 | ||
| Effect of blood collection technique in mice on clinical pathology parameters | Q43846725 | ||
| Recurrence and survival after total mesorectal excision for rectal cancer | Q44519873 | ||
| Biologic brachytherapy: ex vivo transduction of microvascular beds for efficient, targeted gene therapy | Q45859421 | ||
| Ex vivo transduction of microvascular free flaps for localized peptide delivery | Q45875613 | ||
| Treating chronic wound infections with genetically modified free flaps | Q45884279 | ||
| Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients. | Q50919391 | ||
| P433 | issue | 10 | |
| P921 | main subject | chemotherapy | Q974135 |
| xenograft | Q64148587 | ||
| P304 | page(s) | 434-440 | |
| P577 | publication date | 2014-09-19 | |
| P1433 | published in | Cancer Gene Therapy | Q15763088 |
| P1476 | title | Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models | |
| P478 | volume | 21 |
| Q36854725 | A Therapeutic Role for Survivin in Mitigating the Harmful Effects of Ionizing Radiation |
| Q42029049 | Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro |
| Q51156646 | Diamagnetic Imaging Agents with a Modular Chemical Design for Quantitative Detection of β-Galactosidase and β-Glucuronidase Activities with CatalyCEST MRI. |
| Q33598379 | Targeting assay of a fusion protein applied in enzyme prodrug therapy |
Search more.